The omega-3 endocannabinoid DHEA (from DHA) was more potent than its parent fatty acid in raising seizure thresholds in mice, acting through CB1 but not CB2 receptors, while the EPA-derived equivalent EPEA had no effect.
Epilepsy researchers, neuropharmacologists, nutritional neuroscience investigators
DHEA more potent than parent molecule DHA in raising seizure thresholds
What the researchers found
DHEA (100-300 uM) significantly increased seizure threshold within 10 minutes, more potently than its parent molecule DHA (which required 300 uM and 15 minutes). EPEA had no effect at any dose. The CB1 antagonist AM251 fully blocked the anti-seizure effects of both DHA and DHEA, while the CB2 antagonist AM630 did not.
Why it matters
This is the first report showing that DHEA, an omega-3 endocannabinoid, has direct anti-seizure activity via CB1 receptors. This connects the well-known neuroprotective effects of omega-3 fatty acids to the endocannabinoid system, suggesting a new mechanism.
The numbers in context
DHEA effective at 100 and 300 uM at 10 minutes; DHA effective at 300 uM at 15 minutes; EPEA ineffective at 300 and 1000 uM; AM251 (CB1 antagonist) fully blocked effects; AM630 (CB2 antagonist) did not block effects
How the study worked
Mice received intracerebroventricular injections of DHA, DHEA, EPEA, and cannabinoid receptor antagonists. Seizure threshold was measured by intravenous PTZ infusion at 10 and/or 15 minutes post-administration.
What this study cannot tell us
Intracerebroventricular delivery is not clinically practical. Acute seizure model may not reflect chronic epilepsy. Chemical threshold model (PTZ) is one of several seizure types. Small sample sizes typical of pharmacological studies.
How to read the evidence
Novel mechanistic finding in an acute seizure model, but limited by non-translatable delivery route and acute testing paradigm.
When this study was published
Published in 2021.
The bigger picture
Connecting omega-3 fatty acid neuroprotection to the endocannabinoid system opens new avenues for understanding both nutritional approaches to seizure management and the broader role of dietary lipids in brain function.
Questions still open
- Would dietary DHA supplementation increase brain DHEA levels enough to raise seizure thresholds? Could DHEA or a stabilized analog be developed as an anti-epileptic drug?
Common questions
How are omega-3 fatty acids related to the endocannabinoid system?
Could fish oil help with seizures?
Read the original research
The ω-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors.
Brain research bulletin, 170, 74-80
Citation
Ghanbari, Mohammad-Mahdi; Loron, Ali Gharibi; Sayyah, Mohammad. (2021). The ω-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors.. Brain research bulletin, 170, 74-80. https://doi.org/10.1016/j.brainresbull.2021.02.011
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk